Search results
MAIA Biotechnology reports promising Phase 2 trial results By Investing.com
Investing.com· 4 hours agoThe recently presented data at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting...
Chemotherapy type can be personalized to decrease | Newswise
Newswise· 2 days agoTaxane-based chemotherapies are the primary curative therapy for breast cancer, but they can lead to...
Research lab aims to revolutionise cancer treatments
BBC via Yahoo News· 3 hours ago"How lucky are we in Manchester to have this on our doorstep," she said. The 60-year-old said the chemotherapy offered when she was being treated was...
Research showing that with cancer treatment, less can be more
Houston Today· 1 day agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Chemo Before, After Surgery Could Help Those Battling Esophageal Cancer | FOX 28 Spokane
FOX 28 Spokane· 12 hours agoPeople battling advanced esophageal cancers should get doses of chemotherapy both before and after...
Chemotherapy Could Soon Be a Thing of the Past
Bloomberg· 4 days agoHi, it’s Chloé and Ashleigh in London, where we’ve been asking experts whether chemotherapy might one day be eliminated. But first...
Chemo Before, After Surgery Could Help Those Battling Esophageal Cancer
Alaska Superstation· 12 hours agoPeople battling advanced esophageal cancers should get doses of chemotherapy both before and after...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 12 hours agoThe Tagrisso regimen is intended for treating patients with locally advanced or metastatic epidermal...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 2 hours agoThe study included 42 patients suffering from mismatch repair deficient (dMMR) locally advanced...
Closure of Gaza's only route out leaves boy, 10, with no treatment for cancer
Reuters via Yahoo News· 9 hours agoSiraj Yassin, 10, is rolled into the overcrowded Gaza hospital ward in his wheelchair, his light...